Inventor · disambiguated record
Jamie Singer
Also filed as: SINGER JAMIE · SINGER JAMIE MARIE
13 granted patents·2 pending applications·43 citations·filing 2003–2024
90Inventor score
Files withPROVECTUS PHARMATECH INC5PROVECTUS PHARMACEUTICALS INC4SINGER JAMIE2UNIV ROCKEFELLER2EAGLE CRAIG J1
Top patents by PatentIndex Score
15 records- 0188US10471144B2Combination of local rose bengal and systemic immunomodulative therapies for enhanced treatment of cancerPROVECTUS PHARMATECH INC·Filed 2017·Granted Nov 12, 2019·5 cites·26 claims
- 0286US9839688B2Combination of rose bengal and systemic immunomodulative therapies for enhanced treatment of cancerPROVECTUS PHARMACEUTICALS INC·Filed 2015·Granted Dec 12, 2017·5 cites·26 claims
- 0386US9808524B2Combination of local and systemic immunomodulative therapies for melanoma and liver cancerPROVECTUS PHARMACEUTICALS INC·Filed 2015·Granted Nov 7, 2017·5 cites·25 claims
- 0486US9107887B2Combination of local and systemic immunomodulative therapies for enhanced treatment of cancerEAGLE CRAIG J·Filed 2012·Granted Aug 18, 2015·12 cites·12 claims
- 0582US10130658B2Method of ex vivo enhancement of immune cell activity for cancer immunotherapy with a small molecule ablative compoundSINGER JAMIE·Filed 2015·Granted Nov 20, 2018·5 cites·26 claims
- 0681US12377068B2In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumorsPROVECTUS PHARMATECH INC·Filed 2024·Granted Aug 5, 2025·0 cites·6 claims
- 0781US11058664B2In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumorsPROVECTUS PHARMATECH INC·Filed 2019·Granted Jul 13, 2021·1 cites·13 claims
- 0877US8530675B2Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one (rose bengal) and related xanthenesSINGER JAMIE·Filed 2010·Granted Sep 10, 2013·4 cites·83 claims
- 0976US11426379B2Combination of local and systemic therapies for enhanced treatment of dermatologic conditionsUNIV ROCKEFELLER·Filed 2018·Granted Aug 30, 2022·1 cites·6 claims
- 1075US9273022B2Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′, 4′, 5′7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one (Rose Bengal) and related xanthenesPROVECTUS PHARMACEUTICALS INC·Filed 2014·Granted Mar 1, 2016·2 cites·55 claims
- 1174US9422260B2Process for the synthesis of 4,5,6,7-tetrachloro-3′,6′-dihydroxy-2′,4′,5′,7′-tetraiodo-3H-spiro[isobenzofuran-1,9′-xanthen]-3-one(Rose Bengal) and related xanthenesPROVECTUS PHARMACEUTICALS INC·Filed 2013·Granted Aug 23, 2016·2 cites·11 claims
- 1270US11974980B2In vitro and xenograft anti-tumor activity of a halogenated-xanthene against refractory pediatric solid tumorsPROVECTUS PHARMATECH INC·Filed 2021·Granted May 7, 2024·0 cites·9 claims
- 1358US2022054449A1Combination Of Local And Systemic Therapies For Enhanced Treatment of Dermatologic ConditionsUNIV ROCKEFELLER·Filed 2021·Application pending·0 cites
- 1457US7101886B2Phenylalkyl and pyridylalkyl piperazine derivativesWARNER LAMBERT CO·Filed 2003·Granted Sep 5, 2006·1 cites·14 claims
- 1550US2019030074A1Method of Ex Vivo Enhancement of Immune Cell Activity for Cancer Immunotherapy with a Small Molecule Ablative CompoundPROVECTUS PHARMATECH INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jamie Singer files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →